Unison Advisors LLC Purchases New Position in USANA Health Sciences, Inc. (NYSE:USNA)

Unison Advisors LLC acquired a new position in shares of USANA Health Sciences, Inc. (NYSE:USNA - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 18,000 shares of the company's stock, valued at approximately $683,000. Unison Advisors LLC owned approximately 0.09% of USANA Health Sciences as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also added to or reduced their stakes in the stock. CWM LLC grew its position in shares of USANA Health Sciences by 21.8% during the 1st quarter. CWM LLC now owns 1,543 shares of the company's stock valued at $75,000 after purchasing an additional 276 shares in the last quarter. BOKF NA grew its position in USANA Health Sciences by 274.5% during the first quarter. BOKF NA now owns 2,771 shares of the company's stock worth $133,000 after buying an additional 2,031 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in USANA Health Sciences by 9.2% during the first quarter. Price T Rowe Associates Inc. MD now owns 5,849 shares of the company's stock worth $284,000 after buying an additional 494 shares in the last quarter. DGS Capital Management LLC increased its stake in USANA Health Sciences by 61.8% in the 1st quarter. DGS Capital Management LLC now owns 7,258 shares of the company's stock worth $352,000 after acquiring an additional 2,773 shares during the last quarter. Finally, SG Americas Securities LLC purchased a new stake in shares of USANA Health Sciences in the 2nd quarter valued at about $340,000. Institutional investors own 54.25% of the company's stock.

USANA Health Sciences Price Performance

USNA stock traded up $0.36 during mid-day trading on Thursday, hitting $35.79. 85,977 shares of the stock were exchanged, compared to its average volume of 80,232. The stock has a market capitalization of $681.84 million, a price-to-earnings ratio of 11.15, a PEG ratio of 1.20 and a beta of 0.89. The business has a fifty day moving average price of $38.61 and a 200 day moving average price of $43.29. USANA Health Sciences, Inc. has a 12 month low of $34.76 and a 12 month high of $58.73.

USANA Health Sciences (NYSE:USNA - Get Free Report) last issued its earnings results on Tuesday, July 23rd. The company reported $0.54 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.65 by ($0.11). The firm had revenue of $212.87 million during the quarter, compared to analysts' expectations of $218.64 million. USANA Health Sciences had a return on equity of 11.13% and a net margin of 6.29%. During the same period in the prior year, the company earned $0.89 EPS. As a group, equities analysts forecast that USANA Health Sciences, Inc. will post 2.5 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on USNA shares. StockNews.com cut shares of USANA Health Sciences from a "strong-buy" rating to a "buy" rating in a research report on Wednesday, July 24th. DA Davidson decreased their price target on shares of USANA Health Sciences from $46.00 to $38.00 and set a "neutral" rating on the stock in a report on Thursday, July 25th.

Insiders Place Their Bets

In related news, insider Paul A. Jones sold 6,266 shares of the stock in a transaction dated Tuesday, August 13th. The stock was sold at an average price of $38.38, for a total transaction of $240,489.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, Director Gilbert A. Fuller sold 674 shares of the company's stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $39.69, for a total transaction of $26,751.06. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Paul A. Jones sold 6,266 shares of the firm's stock in a transaction dated Tuesday, August 13th. The stock was sold at an average price of $38.38, for a total value of $240,489.08. The disclosure for this sale can be found here. Insiders sold 7,940 shares of company stock valued at $311,670 over the last three months. Insiders own 0.33% of the company's stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.